In addition, activation of PERK has been implicated in a wide variety of cancers, as it enhances responses to chemotherapy [18,19,20,21,22,23,24], while knockdown of PERK in MM cells resulted in autophagic cell death [25]. The gene discussed is EIF2AK3; the disease is Miyoshi myopathy.